Konferenzschrift | Kongress
"Lung cancer: novel therapy against malfunctioning molecules"
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
28 cm
- Umfang
-
72 S.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Literaturangaben
- Erschienen in
-
Cancer chemotherapy and pharmacology ; Vol. 58, Suppl. 1
- Schlagwort
-
Lungenkrebs
Therapie
Krebs
Onkologie
Lunge
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin, Heidelberg
- (wer)
-
Springer
- (wann)
-
2006
- Beteiligte Personen und Organisationen
-
Ariyoshi, Yutaka
Bristol-Myers Squibb KK
Nagoya International Cancer Treatment Symposium (21 : 2006 : Nagoya)
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Konferenzschrift
- Kongress
Beteiligte
- Ariyoshi, Yutaka
- Bristol-Myers Squibb KK
- Nagoya International Cancer Treatment Symposium (21 : 2006 : Nagoya)
- Springer
Entstanden
- 2006
Ähnliche Objekte (12)
Evaluation of ITGA2 as a lung cancer marker and potential target for lung cancer therapy
Lung cancer
Lung cancer
Tumor therapy – Fast ions in the fight against cancer
Validation of CCR2-targeted mesoporous silica nanoparticles for lung cancer therapy
Implementing WHO recommendations for palliative care into routine lung cancer therapy
Spatial metabolomics for therapy response prediction in gastric and lung cancer patients
Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy
Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy
Non-invasive molecular profiling for therapy monitoring of ALK+ lung cancer [Abstract]
Small cell lung cancer
Investigation of molecular mechanisms of therapy resistance in lung cancer by mathematical modeling
Evaluation of ITGA2 as a lung cancer marker and potential target for lung cancer therapy
Lung cancer
Lung cancer
Tumor therapy – Fast ions in the fight against cancer
Validation of CCR2-targeted mesoporous silica nanoparticles for lung cancer therapy
Implementing WHO recommendations for palliative care into routine lung cancer therapy
Spatial metabolomics for therapy response prediction in gastric and lung cancer patients
Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy
Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy
Non-invasive molecular profiling for therapy monitoring of ALK+ lung cancer [Abstract]
Small cell lung cancer
Investigation of molecular mechanisms of therapy resistance in lung cancer by mathematical modeling
Evaluation of ITGA2 as a lung cancer marker and potential target for lung cancer therapy
Lung cancer
Lung cancer
Tumor therapy – Fast ions in the fight against cancer
Validation of CCR2-targeted mesoporous silica nanoparticles for lung cancer therapy
Implementing WHO recommendations for palliative care into routine lung cancer therapy
Spatial metabolomics for therapy response prediction in gastric and lung cancer patients
Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy
Defective DNA repair in EGFR-mutant lung cancer : opportunities for targeted therapy
Non-invasive molecular profiling for therapy monitoring of ALK+ lung cancer [Abstract]
Small cell lung cancer